High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer

BACKGROUND: Transmembrane protein 180 (TMEM180) is a newly identified colorectal cancer (CRC)-specific molecule that is expressed very rarely in normal tissue and up-regulated under hypoxic conditions. We developed a monoclonal antibody (mAb) against TMEM180 and decided to examine the medical signif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Shiraishi, Takuya, Ikeda, Koji, Tsukada, Yuichiro, Nishizawa, Yuji, Sasaki, Takeshi, Ito, Masaaki, Kojima, Motohiro, Ishii, Genichiro, Tsumura, Ryo, Saijou, Sinji, Koga, Yoshikatsu, Yasunaga, Masahiro, Matsumura, Yasuhiro
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7989078/
https://ncbi.nlm.nih.gov/pubmed/33757462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08046-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars